Direkt zum Inhalt

Dorn, Christoph ; Nowak, Hartmuth ; Weidemann, Caroline ; Martini, Stefan ; Zeitlinger, Markus ; Adamzik, Michael ; Kees, Frieder K.

Decreased protein binding of moxifloxacin in patients with sepsis?

Dorn, Christoph , Nowak, Hartmuth, Weidemann, Caroline, Martini, Stefan, Zeitlinger, Markus, Adamzik, Michael und Kees, Frieder K. (2017) Decreased protein binding of moxifloxacin in patients with sepsis? GMS Infectious Diseases 2017 (5), Doc03.

Veröffentlichungsdatum dieses Volltextes: 06 Apr 2018 06:40
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.36969


Zusammenfassung

The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population compared with the value of 58–60% provided in the Summary of Product Characteristics. However, previous investigations neglected the influence of pH ...

The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population compared with the value of 58–60% provided in the Summary of Product Characteristics. However, previous investigations neglected the influence of pH and temperature on the protein binding of moxifloxacin. Maintaining physiological conditions (pH 7.4, 37°C) – as in the present study – the unbound fraction of moxifloxacin in plasma from healthy volunteers was 84%. In contrast, the unbound fraction of moxifloxacin was 77% at 4°C and 66–68% in unbuffered plasma or at pH 8.5 in fair agreement with previously published data. PK/PD parameters e.g. fAUC/MIC or ratios between interstitial fluid and free plasma concentrations, which were obtained assuming a protein binding rate of moxifloxacin of 40% or more, should be revised.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftGMS Infectious Diseases
Verlag:Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.
Band:2017
Nummer des Zeitschriftenheftes oder des Kapitels:5
Seitenbereich:Doc03
Datum3 Februar 2017
InstitutionenChemie und Pharmazie > Institut für Pharmazie > Arbeitsgruppe Klinische Pharmazie (Dr. Dorn)
Identifikationsnummer
WertTyp
10.3205/id000029DOI
Stichwörter / Keywordsfluoroquinolone, unbound fraction, ultrafiltration, septic shock
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenJa
URN der UB Regensburgurn:nbn:de:bvb:355-epub-498968
Dokumenten-ID36969

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben